Stock analysis for Savara Inc (SVRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SVRA Stock Quote - Savara Inc. Common Stock Price - Nasdaq Stock quote for Savara Inc. Common Stock Common Stock (SVRA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Events | SVRA svra to live-stream races at nine speedtour weekends in 2020 SKINNER, BENSON ADD NASCAR MUSCLE TO ROAD ATLANTA VROC FIELD VROC CHAMPS RIBBS, JONES, DALLENBACH ENTER SVRA …
Find the latest Savara, Inc. (SVRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 23, 2020 Real-time trade and investing ideas on Savara Inc SVRA from the largest community of traders and investors. SVRA | Complete Savara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Prev Close 2.03, 52 Wk Low 0.69. Open 1.90, 52 Wk High 11.96. Day Low 1.84, Volume 269,863.00. Day High 2.10, Avg 10D Vol 257,030.00 Get breaking news and analysis on Savara Inc. (SVRA) stock, price quote and chart, trading and investing tools.
Nov 09, 2019 · Their average twelve-month price target is $8.60, suggesting that the stock has a possible upside of 265.96%. The high price target for SVRA is $17.00 and the low price target for SVRA is $1.00. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Savara Inc. (SVRA) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Savara Inc. (SVRA) stock, price quote and chart, trading and investing tools.
rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on SVRA. Stocks by Morningstar Classification
NewsSee all news. 02 April 2020 Savara Obtains Global Rights to Develop and Commercialize Apulmiq. Management to Host Conference Call / Webcast with Bronchiectasis Expert Dr. James Chalmers Savara Inc. (NASDAQ:SVRA), an orphan lung disease company, today announced the Company has entered into an exclusive license SVRA -- Is Its Stock Price A Worthy Investment? Learn More. Savara, Inc. (SVRA) Company Bio Savara Inc., a clinical-stage specialty pharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Read This Before Selling Savara Inc. (NASDAQ:SVRA) Shares ... NasdaqGS:SVRA Recent Insider Trading, February 5th 2020. There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them). Insider Ownership SVRA - Savara Stock Analyst Ratings - Barchart.com Analyst Ratings for Savara Inc (SVRA) provide recommendations made by outside industry experts. Analyst Ratings for Savara Inc (SVRA) provide recommendations made by outside industry experts. The information presented on the graph represents the number of industry analysts that currently rank the stock on the 1 to 5 scale. The greater the
See SVRA stock predictions by 1 financial experts and find out if their Savara stock forecast (SVRA) is more bullish in comparison to other stocks in the Healthcare sector.
Events | SVRA svra to live-stream races at nine speedtour weekends in 2020 SKINNER, BENSON ADD NASCAR MUSCLE TO ROAD ATLANTA VROC FIELD VROC CHAMPS RIBBS, JONES, DALLENBACH ENTER SVRA … SVRA Savara Inc. Stock Quote - FINVIZ.com Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection.